Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature.
about
Improving the performance of phase-change perfluorocarbon droplets for medical ultrasonography: current progress, challenges, and prospects.Stability of echogenic liposomes as a blood pool ultrasound contrast agent in a physiologic flow phantom.Impulse response method for characterization of echogenic liposomesLoss of echogenicity and onset of cavitation from echogenic liposomes: pulse repetition frequency independence.Encapsulated microbubbles and echogenic liposomes for contrast ultrasound imaging and targeted drug delivery.Nitric oxide pretreatment enhances atheroma component highlighting in vivo with intercellular adhesion molecule-1-targeted echogenic liposomes.Cavitation thresholds of contrast agents in an in vitro human clot model exposed to 120-kHz ultrasound.Therapeutic time window and dose dependence of xenon delivered via echogenic liposomes for neuroprotection in stroke.Relationship between cavitation and loss of echogenicity from ultrasound contrast agents.The impact of bubbles on measurement of drug release from echogenic liposomesBroadband attenuation measurements of phospholipid-shelled ultrasound contrast agents.In vitro measurement of attenuation and nonlinear scattering from echogenic liposomes.Nitric oxide-loaded echogenic liposomes for treatment of vasospasm following subarachnoid hemorrhage.Passive imaging with pulsed ultrasound insonations.Acoustic characterization of echogenic liposomes: frequency-dependent attenuation and backscatter.Targeted Nanocarriers for Imaging and Therapy of Vascular Inflammation.Molecular ultrasound imaging: current status and future directionsIn vivo volumetric intravascular ultrasound visualization of early/inflammatory arterial atheroma using targeted echogenic immunoliposomes.Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia.Liposomal modular complexes for simultaneous targeted delivery of bioactive gases and therapeuticsRecent Advances in Targeted, Self-Assembling Nanoparticles to Address Vascular Damage Due to Atherosclerosis.Nanotechnology in the diagnosis of atherosclerotic disease.Role of freeze-drying in the presence of mannitol on the echogenicity of echogenic liposomes.Delivery of xenon-containing echogenic liposomes inhibits early brain injury following subarachnoid hemorrhage.From Micro- to Nano-Multifunctional Theranostic Platform: Effective Ultrasound Imaging Is Not Just a Matter of Scale
P2860
Q26861530-3A1CC43F-6C7A-4738-AFF3-CF73578413FEQ30380934-D3E9AFB1-1CFB-4D5B-8635-68C40AE25BF4Q30387073-2AA11966-C335-43C8-8A28-474C08747944Q30395085-41797691-5210-4889-92F0-19A0199C6998Q30409097-97B5AF29-7370-46F3-82A9-07FF7DEA6647Q30410620-3AD1307A-AA19-4E1A-B1DA-04E9C1F5319BQ30419740-86971518-C36B-406D-91B6-AEEE821D0118Q30429580-A0622323-3DAE-496B-901C-35F46CD915ECQ30430439-D22BA91A-4DC9-402D-A7D8-61722D1256EDQ30435860-4D2A4998-BAFD-46D5-9B3C-AF06B186B242Q30438378-1524DADB-6E71-4918-9C91-5E2A8CAB3506Q30444512-E4ED9F1E-A06F-4DED-9C16-FC4993FBF457Q30445314-07F3B50A-24B5-4FA3-9472-880FA9CFE953Q30452908-529A64BA-4D82-460F-9A81-EF53F0C4F4DBQ30461828-EF63B7CD-595A-4B82-9D88-41490646479AQ30466992-2285D3F2-507C-40C0-BBD1-1FFCDB8B8E9CQ30474725-08C679E4-D011-4756-AD25-769ACC3D4E05Q30475078-AA45E0AE-1055-4E9A-9A64-3DDB27323574Q30475217-E5C257AE-7720-44A3-8AF6-051F3DB80552Q30476296-495206B9-E6A8-4A4A-81DB-441F4B060A90Q36598388-76B8E678-90DA-4A3A-ACFA-D619137D7F48Q38089761-507E27E6-5CF8-4C26-8CAD-2A467D7044A2Q47209532-BCFB6EB1-1329-4133-B460-BB5B581A32ABQ47870716-D206BB12-6838-4360-AF15-07CD579A3142Q58743249-D0D273ED-583D-4EC7-82BC-3A91FD5947AF
P2860
Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Echogenic liposome composition ...... ty at physiologic temperature.
@ast
Echogenic liposome composition ...... ty at physiologic temperature.
@en
type
label
Echogenic liposome composition ...... ty at physiologic temperature.
@ast
Echogenic liposome composition ...... ty at physiologic temperature.
@en
prefLabel
Echogenic liposome composition ...... ty at physiologic temperature.
@ast
Echogenic liposome composition ...... ty at physiologic temperature.
@en
P2093
P2860
P356
P1476
Echogenic liposome composition ...... ty at physiologic temperature.
@en
P2093
David D McPherson
Hyunggun Kim
Kyle D Buchanan
Robert C Macdonald
Shaoling Huang
P2860
P304
P356
10.1002/JPS.21173
P407
P577
2008-06-01T00:00:00Z